Ads
related to: paid clinical trials
Search results
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
BenefitsPRO· 7 hours agoWalgreens has signed a deal with Boehringer Ingelheim to use its community pharmacies as clinical ...
Beyond Air shares hold Buy rating on positive data from a Phase 1a trial By Investing.com
Investing.com· 6 hours agoBeyond Cancer, a subsidiary of Beyond Air, showcased these findings at the American Society of ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 7 hours agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Motley Fool via Yahoo Finance· 8 hours agoBayer and Roche are both collaborating with Recursion on a few oncology programs. Bayer is on the...
Does Medicare Part D cover prescriptions for clinical trials?
Las Vegas Review-Journal· 4 days agoThere may be a time when that expensive prescription is no longer covered by the clinical trial, and...
These Dentist-Approved Mouthwashes Will Zap Bad Breath and Help Prevent Cavities
Prevention via Yahoo News· 4 hours agoMost toothpastes contain anionic compounds, and mouthrinses contain cationic compounds. When...
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID
Digital Journal· 9 hours agoAethlon Medical, Inc. (NASDAQ: AEMD), with a long history of development for its patented Hemopurifier® blood purification device, just released an update on its planned phase 1 safety, feasibility ...
Summit Therapeutics stock rallies as institutional buyer loads up on shares | Invezz
Invezz· 8 hours agoSummit Therapeutics Inc (NASDAQ: SMMT) says it raised $200 million via an offer it accepted from an...
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 6 days agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
Molecular Templates reports progress in cancer therapy trials By Investing.com
Investing.com· 6 hours agoMolecular Templates, Inc. (NASDAQ:MTEM), a clinical-stage biopharmaceutical company, has announced...